At RSNA 2021, Blackford Analysis is highlighting new artificial intelligence (AI) applications now available on its platform.
The following are new to Blackford's platform, which currently provides access to 56 regulatory-cleared clinical applications, according to the company:
- 3M M*Modal Fluency for Imaging, which combines speech recognition technology, computer-assisted physician documentation, information-enabled workflow management, and productivity-enhancing tools
- Bialogics, which identifies, extracts, and correlates data from diagnostic reports to provide analysis of AI/machine-learning algorithms
- Ebit (Esaote Group) technology, now integrated within the Blackford RIS-cardiovascular information system (CVIS) PACS environment
Also at the meeting, Blackford CEO Ben Panter will deliver an industry presentation titled "What's Holding AI Back?" on Wednesday, December 1, at 11:30 a.m. CST.
